These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8101638)

  • 1. Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy.
    Stoessl AJ; Polanski E
    Neuropharmacology; 1993 Jun; 32(6):555-60. PubMed ID: 8101638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1989; 98(3):372-9. PubMed ID: 2568657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagal mediation of the cholecystokinin satiety effect in rats.
    Lorenz DN; Goldman SA
    Physiol Behav; 1982 Oct; 29(4):599-604. PubMed ID: 6294698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats.
    Reidelberger RD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):R1354-8. PubMed ID: 1481948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anorexigenic effect of cholecystokinin octapeptide in a goldfish model is mediated by the vagal afferent and subsequently through the melanocortin- and corticotropin-releasing hormone-signaling pathways.
    Kang KS; Yahashi S; Azuma M; Matsuda K
    Peptides; 2010 Nov; 31(11):2130-4. PubMed ID: 20688118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
    Viard E; Zheng Z; Wan S; Travagli RA
    Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin-8s in the nucleus tractus solitarius of vagally deafferented rats.
    Baptista V; Browning KN; Travagli RA
    Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1092-100. PubMed ID: 17122331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagotomy does not affect thermal responsiveness to intrabrain prostaglandin E2 and cholecystokinin octapeptide.
    Sugimoto N; Simons CT; Romanovsky AA
    Brain Res; 1999 Oct; 844(1-2):157-63. PubMed ID: 10536272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat.
    Stoessl AJ; Rajakumar N
    Synapse; 1996 Nov; 24(3):256-61. PubMed ID: 8923666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruletide acts in the abdomen, not in the brain, to produce satiety.
    Smith GP; Jerome C; Kulkosky P; Simansky KJ
    Peptides; 1984; 5(6):1149-57. PubMed ID: 6099563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous cholecystokinin-8 reduces vagal efferent nerve activity in rats through CCK(A) receptors.
    Bucinskaite V; Kurosawa M; Lundeberg T
    Br J Pharmacol; 2000 Apr; 129(8):1649-54. PubMed ID: 10780970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.
    Gunne LM; Häggström JE
    Psychopharmacology (Berl); 1983; 81(3):191-4. PubMed ID: 6139837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine.
    Nylander AG; Chen D; Ding XQ; Norlén P; Håkanson R
    Pharmacol Toxicol; 1997 Mar; 80(3):142-6. PubMed ID: 9101587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin intracerebroventricularly applied stimulates gastric acid secretion.
    Ishikawa T; Osumi Y; Nakagawa T
    Brain Res; 1985 Apr; 333(1):197-9. PubMed ID: 3995287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycine and D-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia.
    Shoham S; Mazeh H; Javitt DC; Heresco-Levy U
    Brain Res; 2004 Apr; 1004(1-2):142-7. PubMed ID: 15033429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vagus nerve participates in CCK-induced Fos expression in hindbrain but not myenteric plexus.
    Sayegh AI; Ritter RC
    Brain Res; 2000 Sep; 878(1-2):155-62. PubMed ID: 10996146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally.
    Bluthé RM; Michaud B; Kelley KW; Dantzer R
    Neuroreport; 1996 Jun; 7(9):1485-8. PubMed ID: 8856703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally administered CCK-8 suppresses activity in mice by a "peripheral-type" CCK receptor.
    Britton DR; Yahiro L; Cullen MJ; Kerwin JF; Kopecka H; Nadzan AM
    Pharmacol Biochem Behav; 1989 Dec; 34(4):779-83. PubMed ID: 2623030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of morphine-induced increases in brain tryptophan hydroxylase activity by systemic pretreatment with CCK-8: no reversal by vagotomy.
    Johannessen JN; Stuckey JA; Phan TH; Boadle-Biber MC
    Brain Res; 1989 Oct; 499(2):357-62. PubMed ID: 2804682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.